Earnings Call · Q2 FY2022·2022-08-23

Q2 22EPS +7.50%·Rev n/aQ1 22EPS -4.76%·Rev n/aQ4 21EPS +34.21%·Rev n/aQ3 21EPS -10.81%·Rev n/a⚠ consensus missing

Cue Biopharma, Inc. CUE

Dan Passeri — Chief Executive Officer

Anish Suri — Chief Scientific Officer

Ken Pienta — Chief Medical Officer

Matteo Levisetti — Senior Vice President, Clinical Development

Kerri Millar — Chief Financial Officer

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CUE calls or request research access.

More CUE calls Browse calls Request research access